Transcription factor NFκB expression and postsurgical organ dysfunction

被引:47
作者
Foulds, S
Galustian, C
Mansfield, AO
Schachter, M
机构
[1] Imperial Coll Sch Med, Div Surg, London, England
[2] Imperial Coll Sch Med, Natl Heart & Lung Inst, London, England
关键词
D O I
10.1097/00000658-200101000-00012
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective To examine the role of neutrophil NF kappaB activation in organ dysfunction after major surgery. Summary Background Data NF kappaB is a transcription factor involved in the signal transduction of many stimuli that may participate in the pathogenesis of sepsis and resultant multiple organ dysfunction syndrome (MODS). It may therefore be a potential target for modulation in the reduction of postsurgical MODS. Methods Twenty-five patients undergoing major vascular surgery (thoracoabdominal aortic aneurysm repair) were studied. Perioperative levels of neutrophil NF kappaB, CD11b, and glutathione were measured. In vitro inhibition experiments using NF kappaB inhibitors were also performed. Results No differences in clinical parameters were apparent before surgery between the patients who subsequently developed MODS and those who did not. However, there was a significant difference in preoperative levels of NF kappaB between the patients who developed postoperative organ dysfunction and those who did not. There was also a significant preoperative difference between patients who survived surgery and those who did not. Glutathione levels were reduced both in patients who developed MODS and those who did not at the onset of surgery. NF kappaB inhibitors suppressed patient plasma-stimulated NF kappaB activation in healthy neutrophils. Conclusions Preoperative neutrophil NF kappaB status may be a marker of postoperative outcome after major surgery, and therapy aimed at attenuating neutrophil NF kappaB activation may reduce postoperative sepsis and organ dysfunction.
引用
收藏
页码:70 / 78
页数:9
相关论文
共 53 条
[1]  
ABELLO PA, 1994, ADV EXP MED BIOL, V366, P253
[2]   EFFICACY AND SAFETY OF MONOCLONAL-ANTIBODY TO HUMAN TUMOR-NECROSIS-FACTOR-ALPHA IN PATIENTS WITH SEPSIS SYNDROME - A RANDOMIZED, CONTROLLED, DOUBLE-BLIND, MULTICENTER CLINICAL-TRIAL [J].
ABRAHAM, E ;
WUNDERINK, R ;
SILVERMAN, H ;
PERL, TM ;
NASRAWAY, S ;
LEVY, H ;
BONE, R ;
WENZEL, RP ;
BALK, R ;
ALLRED, R ;
PENNINGTON, JE ;
WHERRY, JC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 273 (12) :934-941
[3]   SEPARATION OF OXIDANT-INITIATED AND REDOX-REGULATED STEPS IN THE NF-KAPPA-B SIGNAL-TRANSDUCTION PATHWAY [J].
ANDERSON, MT ;
STAAL, FJT ;
GITLER, C ;
HERZENBERG, LA ;
HERZENBERG, LA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (24) :11527-11531
[4]  
BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141
[5]   Nuclear factor kappa B [J].
Barnes, PJ .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 1997, 29 (06) :867-870
[6]   Lipopolysaccharide signal transduction, regulation of tumor necrosis factor biosynthesis, and signaling by tumor necrosis factor itself [J].
Beutler, B ;
Kruys, V .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1995, 25 :S1-S8
[7]   The role of nuclear factor-kappa B in cytokine gene regulation [J].
Blackwell, TS ;
Christman, JW .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1997, 17 (01) :3-9
[8]   Role of NF kappa B in the mortality of sepsis [J].
Bohrer, H ;
Qiu, F ;
Zimmerman, T ;
Zhang, YM ;
Jllmer, T ;
Mannel, D ;
Bottiger, BW ;
Stern, DM ;
Waldherr, R ;
Saeger, HD ;
Ziegler, R ;
Bierhaus, A ;
Martin, E ;
Nawroth, PP .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (05) :972-985
[9]   DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS [J].
BONE, RC ;
BALK, RA ;
CERRA, FB ;
DELLINGER, RP ;
FEIN, AM ;
KNAUS, WA ;
SCHEIN, RMH ;
SIBBALD, WJ .
CHEST, 1992, 101 (06) :1644-1655
[10]   POSTINJURY NEUTROPHIL PRIMING AND ACTIVATION - AN EARLY VULNERABLE WINDOW [J].
BOTHA, AJ ;
MOORE, FA ;
MOORE, EE ;
KIM, FJ ;
BANERJEE, A ;
PETERSON, VM .
SURGERY, 1995, 118 (02) :358-365